Journal Home
Search for

Volume 41, Issue 3, Pages 199-204 (December 2009)


View previous. 10 of 18 View next.

The influence of riboflavin photochemistry on plasma coagulation factors

Luis LarreaaCorresponding Author Informationemail address, María Calabuiga, Vanesa Roldánb, José Riverab, Han-Mou Tsaic, Vicente Vicenteb, Roberto Roiga

Abstract 

Studies with riboflavin in the 1960s showed that it could be effective at inactivating pathogens when exposed to light. The principal mode of action is through electron transfer reactions, most importantly in nucleic acids. This suggested that it could act as a photosensitizer useful in the inactivation of pathogens found in blood products.

Objective

To study the influence of photo-inactivation with riboflavin on the coagulation factors of plasma.

Methods

The photo-inactivation procedure of riboflavin plus light was applied. Fifty isogroup pools of two plasmas were made from 100U of plasma that were derived from whole blood products that had previously been held overnight. Pools were split into two bags. One of them was photo-inactivated, and post inactivation samples were obtained. The second bag was not photo-inactivated and samples were taken. Total protein, fibrinogen, FII, FV, FVII, FVIII, FIX, FX, FXI, FXIII, antithrombin III, PC, PS, α-2 antiplasmin and vWF:Ag, the multimeric structure of vWF and ADAMTS-13 were analyzed.

Results

In plasma, the proteins most sensitive to photo-inactivation were fibrinogen, FXI, FVIII, FV, and FIX (33%, 32%, 30%, 18% and 18% loss, respectively). Coagulation inhibitors, PS, antithrombin III and PC showed little decrease (all 2%). Retention of vWF and ADAMTS-13 were 99% and 88%, respectively.

Conclusions

As with other pathogen reduction procedures for plasma products, treatment with riboflavin and UV light resulted in reduction in the activity levels of several pro-coagulant factors. Coagulation inhibitors are well preserved.

a Centro de Transfusión de la Comunidad Valenciana, Processing Department, Spain

b Centro Regional de Hemodonacion, Unit of Hematology–Oncology, Spain

c Montefiore Medical Center/Albert Einstein Collage of Medicine, Division of Hematology, Spain

Corresponding Author InformationCorresponding author. Address: Avda Del Cid 65, 46014 Valencia, Spain. Tel.: +34 963868143; fax: +34 963502469.

PII: S1473-0502(09)00143-8

doi:10.1016/j.transci.2009.09.006


View previous. 10 of 18 View next.